However, management of the latter remains challenging as although c-reactive protein (CRP) is the most robust biomarker to identify cachexia inflammation, it is neither specific for cancer, cachexia or for tumour activity as it can be influenced by other factors such as infections [22]. Here, CRP is linked to infection.